Port Site Metastasis in Women with Low- or Intermediate-Risk Endometrial Carcinoma: A Systematic Review of Literature.
Cancers (Basel)
; 16(15)2024 Jul 27.
Article
en En
| MEDLINE
| ID: mdl-39123410
ABSTRACT
Background:
Port site metastasis (PSM) has been reported as a rare metastasis in women with endometrial carcinoma (EC). However, even more rarely, it has also been described in patients with low- or intermediate-risk EC. Unfortunately, knowledge appears limited on the topic.Objectives:
Our objective was to systematically review the literature on PSM in low- or intermediate-risk EC. Search Strategy A systematic review of the literature was performed by searching six electronic databases from their inception to January 2023. Selection Criteria We included in our research all peer-reviewed studies which reported PSM in low- or intermediate-risk EC women. Data Collection andAnalysis:
Data on PSM were collected from the included studies and compared.Results:
Seven studies with 13 patients (including our case) were included in the systematic review. PSM was reported in patients with low- or intermediate-risk EC independently from tumor histologic characteristics, endoscopic approach, lymph node staging type, number and site of the port, route of specimen removal, prevention strategies for PSM, and concomitant metastases. Among several proposed treatments, local resection and radiotherapy with or without chemotherapy might be the most appropriate ones. Nevertheless, the prognosis appears poor.Conclusions:
In patients with low- or intermediate-risk EC, PSM can occur as a rare metastasis, regardless of tumor characteristics or surgical strategy. Unfortunately, no consensus has been reached regarding treatment, and the prognosis appears poor. Additional cases are needed in order to confirm and further explore this rare EC metastasis.
Texto completo:
1
Base de datos:
MEDLINE
Idioma:
En
Revista:
Cancers (Basel)
Año:
2024
Tipo del documento:
Article
País de afiliación:
Italia